IL-33 Aggravates DSS-Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell Responses

Figure 1

Administration of rIL-33 results in exacerbation of DSS-induced acute colitis. (a) Weight loss, survival rate, and disease activity index; (b) histological score (original magnification, ×200); (c) macroscopic changes and colon length. Data indicate mean ± SD of 8 mice of each group obtained from a representative of three independent experiments ( per group). ^∗, ^∗∗, and ^#.

(a)

(b)

(c)